1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells - PubMed (original) (raw)

. 2007 Jan 15;263(1-2):55-64.

doi: 10.1016/j.mce.2006.08.009. Epub 2006 Oct 9.

Affiliations

• PMID: 17029768
• DOI: 10.1016/j.mce.2006.08.009

1alpha,25-dihydroxyvitamin D3 downregulates CYP27B1 and induces CYP24A1 in colon cells

Daniel Lechner et al. Mol Cell Endocrinol. 2007.

Abstract

The antimitotic and prodifferentiating 1alpha,25-dihydroxyvitamin D3 (1alpha,25-(OH)2D3), synthesized at various extrarenal sites could potentially prevent sporadic tumor development. Physiological regulation of extrarenal Vitamin D hydroxylases following tissue accumulation of 1alpha,25-(OH)2D3 is unknown. We therefore investigated basal and Vitamin D-regulated expression and activity of the synthesizing (CYP27B1) and metabolizing (CYP24A1) hydroxylase in three cell lines derived from the colon, and compared this to cells from the prostate and mammary gland. Our results show that all cells, irrespective of origin and differentiation, express CYP27B1 mRNA, whereas basal CYP24A1 mRNA is highly expressed only in undifferentiated cells. Treatment with 1alpha,25-(OH)2D3 diminishes CYP27B1 and Vitamin D receptor mRNA expression, but elevates CYP24A1 mRNA to equal levels in all cells. As shown by HPLC, CYP27B1 is active only if basal 24-hydroxylation is not maximally functional. In turn, accumulation of 1alpha,25-(OH)2D3 will induce 24-hydroxylation. We conclude that, although extrarenal and renal metabolic pathways for Vitamin D are similar, malignancy of tumor cells determines extent of Vitamin D catabolism.

PubMed Disclaimer

Similar articles

• Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
  Chow EC, Quach HP, Vieth R, Pang KS. Chow EC, et al. Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E977-89. doi: 10.1152/ajpendo.00489.2012. Epub 2013 Mar 12. Am J Physiol Endocrinol Metab. 2013. PMID: 23482451
• Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
  Bareis P, Kállay E, Bischof MG, Bises G, Hofer H, Pötzi C, Manhardt T, Bland R, Cross HS. Bareis P, et al. Exp Cell Res. 2002 Jun 10;276(2):320-7. doi: 10.1006/excr.2002.5528. Exp Cell Res. 2002. PMID: 12027461
• Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
  Masuda S, Byford V, Arabian A, Sakai Y, Demay MB, St-Arnaud R, Jones G. Masuda S, et al. Endocrinology. 2005 Feb;146(2):825-34. doi: 10.1210/en.2004-1116. Epub 2004 Oct 21. Endocrinology. 2005. PMID: 15498883
• Metabolism of vitamin D3 by cytochromes P450.
  Sakaki T, Kagawa N, Yamamoto K, Inouye K. Sakaki T, et al. Front Biosci. 2005 Jan 1;10:119-34. doi: 10.2741/1514. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15574355 Review.
• Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.
  Meyer MB, Pike JW. Meyer MB, et al. J Steroid Biochem Mol Biol. 2020 Feb;196:105500. doi: 10.1016/j.jsbmb.2019.105500. Epub 2019 Oct 16. J Steroid Biochem Mol Biol. 2020. PMID: 31629064 Free PMC article. Review.

Cited by

• The Cysteine Protease Legumain Is Upregulated by Vitamin D and Is a Regulator of Vitamin D Metabolism in Mice.
  Forbord KM, Okla M, Lunde NN, Bosnjak-Olsen T, Arnekleiv G, Hesselson D, Johansen HT, Tang JCY, Kassem M, Solberg R, Jafari A. Forbord KM, et al. Cells. 2023 Dec 22;13(1):36. doi: 10.3390/cells13010036. Cells. 2023. PMID: 38201240 Free PMC article.
• CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.
  Kósa JP, Horváth P, Wölfling J, Kovács D, Balla B, Mátyus P, Horváth E, Speer G, Takács I, Nagy Z, Horváth H, Lakatos P. Kósa JP, et al. World J Gastroenterol. 2013 May 7;19(17):2621-8. doi: 10.3748/wjg.v19.i17.2621. World J Gastroenterol. 2013. PMID: 23674869 Free PMC article.
• High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis.
  Ghaly S, Kaakoush NO, Lloyd F, McGonigle T, Mok D, Baird A, Klopcic B, Gordon L, Gorman S, Forest C, Bouillon R, Lawrance IC, Hart PH. Ghaly S, et al. Sci Rep. 2018 Jul 31;8(1):11511. doi: 10.1038/s41598-018-29759-y. Sci Rep. 2018. PMID: 30065252 Free PMC article.
• The Relative Expression of ERα Isoforms ERα66 and ERα36 Controls the Cellular Response to 24R,25-Dihydroxyvitamin D3 in Breast Cancer.
  Verma A, Cohen DJ, Jacobs TW, Boyan BD, Schwartz Z. Verma A, et al. Mol Cancer Res. 2021 Jan;19(1):99-111. doi: 10.1158/1541-7786.MCR-20-0169. Epub 2020 Oct 20. Mol Cancer Res. 2021. PMID: 33082240 Free PMC article.
• Action of vitamin D and the receptor, VDRa, in calcium handling in zebrafish (Danio rerio).
  Lin CH, Su CH, Tseng DY, Ding FC, Hwang PP. Lin CH, et al. PLoS One. 2012;7(9):e45650. doi: 10.1371/journal.pone.0045650. Epub 2012 Sep 19. PLoS One. 2012. PMID: 23029160 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program